Caffeine is widely used as a cognitive, physical, and psychomotor booster. Recent studies have suggested worrying trends of overconsumption of caffeine, accompanied by higher risk for multiple diseases, including diabetes mellitus type 2. There's a general lack of research in the middle east regarding caffeine consumption patterns. The aim of this study is to assess caffeine consumption levels among the United Arab Emirates (UAE) adult population, as well as the population general knowledge and attitude regarding its health implications.
Methods:
A cross-sectional study was conducted from July to August 2016 on 403 randomly chosen people from five emirates in the UAE. Self-administered questionnaires were distributed through a nonprobability sampling method. The number of participants selected from each emirate was proportionate to the population size of each city.
Results:
The mean total caffeine consumed per day was 316.7 mg, close to the acceptable daily intake of 400 mg/day. More than 98.5% of the study participants were caffeine consumers, with 31% reported being addicted to caffeine. Caffeine consumption was significantly associated with smoking and people with heart problems. The mean level of knowledge about caffeine was less than 33%. Younger participants (p = 0.008) and those who work in healthcare & education (p < 0.001) were significantly more knowledgeable.
Conclusion:
Caffeine consumption is very prevalent among UAE population, which ranks high among other countries. There is a lack of accurate knowledge regarding the effects of caffeine on health and well-being. Healthy consumption behaviors need to be promoted through a better awareness and transparent environment.
Get full access to this article
View all access options for this article.
References
1.
BolumarF, OlsenJ, RebagliatoM, BisantiL. Caffeine intake and delayed conception: A European multicenter study on infertility and subfecundity. Am J Epidemiol. 1997; 145:324–334.
2.
HirshK. Central nervous system pharmacology of the dietary methylxanthines. Prog Clin Biol Res. 1984; 158:235–301.
3.
TempleJ. Caffeine Use in Children: What we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev. 2009; 33:793–806.
4.
MessinaG, ZannellaC, MondaV, et al.The beneficial effects of coffee in human nutrition. Biol Med (Aligarh). 2015; 7:240.
5.
Gonzalez de MejiaE, Ramirez-MaresMV. Impact of caffeine and coffee on our health. Trends Endocrinol Metab. 2014; 25:489–492.
6.
TurnbullD, RodricksJ, MarianoG. Neurobehavioral hazard identification and characterization for caffeine. Regul Toxicol Pharmacol. 2016; 74:81–92.
7.
MitchellDC, KnightCA, HockenberryJ, TeplanskyR, HartmanTJ. Beverage caffeine intakes in the U.S. Food Chem Toxicol. 2014; 63:136–142.
8.
SmithAP, BriceCF. Factors associated with caffeine consumption. Int J Food Sci Nutr. 2002; 53:55–64.
9.
TranN, BarrajL, BiX, JackM. Trends and patterns of caffeine consumption among US teenagers and young adults, NHANES 2003–2012. Food Chem Toxicol. 2016; 94:227–242.
10.
HeckmanM, WeilJ, de MejiaE. Caffeine (1, 3, 7-trimethylxanthine) in foods: A comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010; 75:R77–R87.
11.
YamadaM, SasakiS, MurakamiK, et al.Estimation of caffeine intake in Japanese adults using 16 d weighed diet records based on a food composition database newly developed for Japanese populations. Public Health Nutr. 2010; 13:663–672.
12.
WikoffD, WelshB, HendersonR, et al.Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol. 2017; 109:585–648.
13.
van DamR, HuF. Coffee consumption and risk of type 2 diabetes. JAMA. 2005; 294:97.
14.
RossGW, AbbottRD, PetrovitchH, et al.Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000; 283:2674–2679.
15.
AscherioA, ZhangSM, HernánMA, et al.Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol. 2001; 50:56–63.
16.
EskelinenM, KivipeltoM. Caffeine as a protective factor in dementia and Alzheimer's disease. J Alzheimers Dis. 2010; 20(S1):167–174.
17.
TianC, WangW, HongZ, ZhangX. Coffee consumption and risk of colorectal cancer: A dose–response analysis of observational studies. Cancer Causes Control. 2013; 24:1265–1268.
18.
GaleoneC, TuratiF, La VecchiaC, TavaniA. Coffee consumption and risk of colorectal cancer: A meta-analysis of case–control studies. Cancer Causes Control. 2010; 21:1949–1959.
19.
HogervorstE, BandelowS, SchmittJ, et al.Caffeine improves physical and cognitive performance during exhaustive exercise. Med Sci Sports Exerc. 2008; 40:1841–1851.
20.
BorotaD, MurrayE, KeceliG, et al.Post-study caffeine administration enhances memory consolidation in humans. Nat Neurosci. 2014; 17:201–203.
21.
JeeS, HeJ, AppelL, WheltonP, SuhI, KlagM. Coffee consumption and serum lipids: A meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001; 153:353–362.
22.
Rodríguez-ArtalejoF, López-GarcíaE. Coffee consumption and cardiovascular disease: A condensed review of epidemiological evidence and mechanisms. J Agric Food Chem. 2018 [Epub ahead of print]; DOI: 10.1021/acs.jafc.7b04506.
23.
ShiraishiM, HarunaM, MatsuzakiM, et al.Relationship between plasma total homocysteine level and dietary caffeine and vitamin B6intakes in pregnant women. Nurs Health Sci. 2013; 16:164–170.
24.
UrgertR, KatanMB. The sholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997; 17:305–324.
25.
ShimamotoT, YamamichiN, KodashimaS, et al.No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: A cross-sectional study of 8,013 healthy subjects in Japan. PLoS One. 2013; 8:e65996.
26.
RapuriP, GallagherJ, KinyamuH, RyschonK. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr. 2001; 74:694–700.
27.
HahnK, WiseLA, RothmanKJ, et al.Caffeine and caffeinated beverage consumption and risk of spontaneous abortion. Hum Reprod. 2015; 30:1246–1255.
28.
RichardsG, SmithA. Caffeine consumption and self-assessed stress, anxiety, and depression in secondary school children. J Psychopharmacol. 2015; 29:1236–1247.
ConnerM, NormanP. Predicting health behaviour. In: Predicting Health Behaviour: A Social Cognition Approach. Mark ConnerM. and NormanP. (Eds). Maidenhead: Open University Press; 2005: p. 21.
33.
EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on the safety of caffeine. EFSA J. 2015; 13:4102.
34.
MackusM, van de LooAJAE, BensonS, ScholeyA, VersterJC. Consumption of caffeinated beverages and the awareness of their caffeine content among Dutch students. Appetite. 2016; 103:353–357.
35.
FittE, PellD, ColeD. Assessing caffeine intake in the United Kingdom diet. Food Chem. 2013; 140:421–426.
36.
FulgoniV, KeastD, LiebermanH. Trends in intake and sources of caffeine in the diets of US adults: 2001–2010. Am J Clin Nutr. 2015; 101:1081–1087.
37.
FraryC, JohnsonR, WangM. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc. 2005; 105:110–113.
38.
TreurJL, TaylorAE, WareJJ, et al.Associations between smoking and caffeine consumption in two European cohorts. Addiction. 2016; 111:1059–1068.
39.
HewlettP, SmithA. Correlates of daily caffeine consumption. Appetite. 2006; 46:97–99.
40.
SutherlandL, KaleyL, FischerL. Guiding Stars: The effect of a nutrition navigation program on consumer purchases at the supermarket. Am J Clin Nutr. 2010; 91:1090S–1094S.
41.
PenolazziBA, NataleVW, LeoneLW, RussoPM. Individual differences affecting caffeine intake. Analysis of consumption behaviours for different times of day and caffeine sources. Appetite. 2012; 58:971–977.
42.
NawrotP, JordanS, EastwoodJ, RotsteinJ, HugenholtzA, FeeleyM. Effects of caffeine on human health. Food Addit Contam. 2003; 20:1–30.
43.
SatelS. Is caffeine addictive?—A review of the literature. Am J Drug Alcohol Abuse. 2006; 32:493–502.
44.
HadžićS, KukićI, ZvorničaninJ. The prevalence of eyelid myokymia in medical students. BJMMR. 2016; 14:1–6.
